Grant Therapeutics Companies

Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.

WIndow Therapeutics discovers and develops transformational therapeutics for cancer.

Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.

Dimension Inx specializes in developing regenerative microenvironments that give the body a blueprint to heal itself.

Axmed is a medical marketplace that offers access to medicines for healthcare providers through business and technology solutions.

LimmaTech Biologics is a biotech company that develops vaccines to prevent microbial infections and address antimicrobial resistance.

Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.

Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.

Iaso Therapeutics develops vaccines to improve human health and cure diseases.

Veana Therapeutics is a Biotechnology Company based in Oregon.

Oxcia is a biopharmaceutical company that provides therapies and DNA damage response mechanisms to treat cancer and inflammatory diseases.

Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.

Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing.

Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.

VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.

Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.

MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics.

PlusVitech develops effective and safe therapeutic treatments and complementary diagnostic tests for cancer patients.

Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases.

Attivare Therapeutics is a biotechnology company that develops small-molecule therapies that modulate immune and inflammatory pathways.

Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.

BrainChild Bio develops CAR-T cell therapies for pediatric brain tumors, focusing on DIPG.

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.